(Q41136367)

English

In VitroActivity of Cefamandole, Cefoxitin, Cefuroxime, and Carbenicillin, Alone and in Combination with Aminoglycosides againstSerratia marcescens1

scientific article published on January 1, 1979

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

In VitroActivity of Cefamandole, Cefoxitin, Cefuroxime, and Carbenicillin, Alone and in Combination with Aminoglycosides againstSerratia marcescens1 (English)

reason for preferred rank

most precise value

1 reference

10.1111/J.1348-0421.1979.TB00526.X

https://api.crossref.org/works/10.1111/J.1348-0421.1979.TB00526.X

18 April 2023

In vitro activity of cefamandole, cefoxitin, cefuroxime, and carbenicillin, alone and in combination with aminoglycosides against Serratia marcescens (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A390321

18 April 2023

Serratia marcescens

object named as

Serratia marcescens

1 reference

based on heuristic

inferred from title

1 reference

10.1111/J.1348-0421.1979.TB00526.X

https://api.crossref.org/works/10.1111/J.1348-0421.1979.TB00526.X

18 April 2023

1 reference

10.1111/J.1348-0421.1979.TB00526.X

https://api.crossref.org/works/10.1111/J.1348-0421.1979.TB00526.X

18 April 2023

author name string

M. A. Miller

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A390321

18 April 2023

M. Yousuf

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A390321

18 April 2023

P. S. Griffin

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A390321

18 April 2023

M. Bartlett

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A390321

18 April 2023

J. K. Crane

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A390321

18 April 2023

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=390321

18 April 2023

publication date

1 January 1979

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1348-0421.1979.tb00526.x

1 reference

10.1111/J.1348-0421.1979.TB00526.X

https://api.crossref.org/works/10.1111/J.1348-0421.1979.TB00526.X

18 April 2023

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1348-0421.1979.tb00526.x/fullpdf

1 reference

10.1111/J.1348-0421.1979.TB00526.X

https://api.crossref.org/works/10.1111/J.1348-0421.1979.TB00526.X

18 April 2023

Microbiology and Immunology

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

955-964

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

Antimicrobial Synergism in the Therapy of Gram-Negative Rod Bacteremia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1979.TB00526.X

21 January 2018

Cefoxitin and cephalothin: antimicrobial activity, human pharmacokinetics, and toxicology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1979.TB00526.X

21 January 2018

Antibiotic Resistance Patterns of Clinical Isolates of Serratia marcescens

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1979.TB00526.X

21 January 2018

Susceptibility of Enterobacter to cefamandole: evidence for a high mutation rate to resistance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1979.TB00526.X

21 January 2018

Cefuroxime: human pharmacokinetics

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1979.TB00526.X

21 January 2018

A Comparative Study of the Activity of Cefamandole and Other Cephalosporins and Analysis of the -Lactamase Stability and Synergy of Cefamandole with Aminoglycosides

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1979.TB00526.X

21 January 2018

Clinical Significance of In Vitro Synergism Between Antibiotics in Gram-Negative Infections

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1979.TB00526.X

21 January 2018

The carbenicillin-gentamicin combination against Pseudomonas aeruginosa. Correlation of effect with gentamicin sensitivity.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1979.TB00526.X

21 January 2018

Synergism of Carbenicillin and Gentamicin Against Enterococci

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1979.TB00526.X

21 January 2018

Amikacin Therapy for Serious Gram-Negative Bacillary Infections

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1979.TB00526.X

21 January 2018

Gentamicin-resistant Pseudomonas aeruginosa and Serratia marcescens in a general hospital

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1979.TB00526.X

21 January 2018

Antibiograms and lipid contents of pigmented and nonpigmented strains of Serratia marcescens

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1979.TB00526.X

21 January 2018

Comparison of the pharmacokinetics of cefamandole and other cephalosporin compounds

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1979.TB00526.X

21 January 2018

Cefuroxime, a Beta-Lactamase-Resistant Cephalosporin with a Broad Spectrum of Gram-Positive and -Negative Activity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1979.TB00526.X

21 January 2018

Cefuroxime, a New Cephalosporin Antibiotic: Activity In Vitro

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1979.TB00526.X

21 January 2018

In vitro activity of gentamicin, amikacin and netilmicin alone and in combination with carbenicillin against Serratia marcescens

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1979.TB00526.X

21 January 2018

Amikacin, an aminoglycoside with marked activity against antibiotic-resistant clinical isolates

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1979.TB00526.X

21 January 2018

Newer aminoglycosides--amikacin and tobramycin: an in-vitro comparison with kanamycin and gentamicin.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1979.TB00526.X

21 January 2018

Comparative study of seven cephalosporins: susceptibility to beta-lactamases and ability to penetrate the surface layers of Escherichia coli

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1979.TB00526.X

21 January 2018

An outbreak of nosocomial infection due to multiply resistant Serratia marcescens: evidence of interhospital spread

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1979.TB00526.X

21 January 2018

Relation of Beta-Lactamase Activity to Antimicrobial Susceptibility in Serratia marcescens

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1979.TB00526.X

21 January 2018

Cefoxitin, a semisynthetic cephamycin antibiotic: susceptibility studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1979.TB00526.X

21 January 2018

Biological properties of three 3-heterocyclic-thiomethyl cephalosporin antibiotics

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1979.TB00526.X

21 January 2018

Netilmicin synergy with carbenicillin or cefamandole against Serratia

8

1 reference

10.1111/J.1348-0421.1979.TB00526.X

https://api.crossref.org/works/10.1111/J.1348-0421.1979.TB00526.X

18 April 2023

Combined antibiotic action: some definitions and correlations between laboratory and clinical results

11

1 reference

10.1111/J.1348-0421.1979.TB00526.X

https://api.crossref.org/works/10.1111/J.1348-0421.1979.TB00526.X

18 April 2023

Antibacterial activity in serum and urine as a therapeutic guide in bacterial infections

13

1 reference

10.1111/J.1348-0421.1979.TB00526.X

https://api.crossref.org/works/10.1111/J.1348-0421.1979.TB00526.X

18 April 2023

Significance of antimicrobial synergism for the outcome of gram negative sepsis

14

1 reference

10.1111/J.1348-0421.1979.TB00526.X

https://api.crossref.org/works/10.1111/J.1348-0421.1979.TB00526.X

18 April 2023

Clinical Pharmacology of Carbenicillin Compared with Other Penicillins

30

1 reference

10.1111/J.1348-0421.1979.TB00526.X

https://api.crossref.org/works/10.1111/J.1348-0421.1979.TB00526.X

18 April 2023

Identifiers

10.1111/J.1348-0421.1979.TB00526.X

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41136367&oldid=1877983070"